• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLC161400J
Device Problems Leak/Splash (1354); Migration or Expulsion of Device (1395); Unintended Collision (1429)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 06/16/2015
Event Type  Injury  
Event Description
On (b)(6) 2015, the patient underwent endovascular repair of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses (b)(4).The stent grafts were deployed in a crossing-leg fashion, and an intra-procedure imaging revealed a suspected proximal type i endoleak.Two aortic extender components were implanted to treat the endoleak, and the procedure was concluded with the endoleak almost all resolved.On (b)(6) 2015, a follow-up imaging revealed a persistent endoleak.When the physician reviewed intra-procedure images taken during the initial procedure, it was revealed that the ipsilateral leg of the (b)(4) had been deployed, pushing up the (b)(4), which had caused it to be almost detached from the contralateral gate.Also, it was revealed that the persistent endoleak was a type iii endoleak.On (b)(6) 2015, another contralateral leg component was implanted to bridge the contralateral gate and the detached (b)(4).The type iii endoleak was resolved, and the patient tolerated the procedure.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
Describe event or problem additional information was obtained and the event description was corrected.
 
Event Description
On (b)(6) 2015, the patient underwent endovascular repair of an abdominal aortic aneurysm using gore excluder aaa endoprostheses (rlt231418j/13549906 and plc161400j/13272921).The stent grafts were deployed in a crossing-leg fashion, and an intra-procedure imaging revealed a suspected proximal type i endoleak.Two aortic extender components were implanted to treat the endoleak, and the procedure was concluded with the endoleak almost all resolved.On (b)(6) 2015, a follow-up imaging revealed a persistent endoleak.When the physician reviewed intra-procedure images taken during the initial procedure, it was revealed that the ipsilateral leg of the rlt231418j had been deployed, pushing the plc161400j outward, which had caused it to be almost detached from the contralateral gate.Also, it was revealed that the persistent endoleak was a type iii endoleak.On (b)(6) 2015, another contralateral leg component was implanted to bridge the contralateral gate and the detached plc161400j.The type iii endoleak was resolved, and the patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4920365
MDR Text Key6016145
Report Number3007284313-2015-00072
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2017
Device Catalogue NumberPLC161400J
Device Lot Number13272921
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
(B)(4)
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
-
-